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Supplementary Materials and Methods 
 
Animals 
GarsC201R/+ and GarsNmf249/+ mice were maintained as heterozygote breeding pairs on a 
predominantly C57BL/6 background as detailed previously (1-3). Ear clips were used 
for DNA extractions as formerly described (4), and animals genotyped using published 
protocols (1-3). Mice sacrificed for one month and three month time points were 28-36 
and 88-97 days old, respectively. Post-natal day 1 (P1) was designated as the day after 
a litter was first found. 
 
DRG dissection and culturing 
Ethanol-sterilised 12 mm coverslips (VWR International, Radnor, PA, 
MENZCB00120RAC20) placed in 24-well plates (Corning, New York, NY, 3524) 
were treated with 20 μg/ml poly-D-lysine (Becton Dickinson, Franklin Lakes, NJ, 
354210) in Ca2+/Mg2+-free Hank's Balanced Salt Solution (HBSS, Thermo Fisher, 
Waltham, MA, 14170) for at least 12 h at 4°C. Wells were washed three times with 
Ca2+/Mg2+-free Dulbecco’s phosphate buffered saline (DPBS, Thermo Fisher, 14190), 
and thoroughly dried. 10-20 μl HBSS containing 20 μg/ml laminin (Sigma Aldrich, St. 
Louis, MO, L2020) was pipetted onto the centre of coverslips to concentrate the 
neurons and incubated at 37°C for 4-6 h. DPBS was pipetted between wells to restrict 
evaporation of the laminin solution. DRG neurons used in calcium imaging experiments 
were plated in 8-well μ-slides (Ibidi, Martinsried, Germany, 80826) treated as above, 
but without coverslips. Before starting the dissection, a previously prepared and frozen 
collagenase/dispase enzyme solution was thawed at 37°C for no longer than 2 h before 
use; 24 mg collagenase type II (1 U/μl, Worthington Biochemical Corporation, 
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Lakewood, NJ, 4176 or Thermo Fisher, 17101015) and 28 mg dispase II (Sigma, 
D4693) were added to 6 ml Ca2+/Mg2+-free HBSS, and filter-sterilised through a 0.22 
μm filter (Appleton Woods, Birmingham, UK, FC121) before aliquotting and freezing. 
DRG were dissected as previously described (5). To limit technical variability, 20-24 
DRG per animal were dissected from thoracic (T1-T13) and lumbar (L1-L5) spinal cord 
regions of one wild-type and one GarsC201R/+ mouse during the same culturing session. 
DRG were enzymatically digested at 37°C for 10 min in collagenase/dispase, before 
manual dissociation in cell medium using a series of fire-polished glass Pasteur pipettes 
(VWR, 612-1701) of descending bore size. Cells were spun down at 1,000 × g for 5 
min, before resuspension. The laminin solution was pipetted off the coverslips/μ-slides 
and a small volume of cells immediately added, with genotypes plated at similar 
densities. Cells were kept at 37°C in a 5% (v/v) CO2 humidified atmosphere. After 1-2 
h, plate and μ-slide wells were flooded with media to a total volume of 500 μl and 200 
μl, respectively. F12 media + L-glutamine (Thermo Fisher, 11765) was supplemented 
with 10% (v/v) foetal bovine serum (FBS, Thermo Fisher, 10270), 1% (v/v) penicillin-
streptomycin (10,000 U/mL, Thermo Fisher, 15140), and freshly added 20 ng/ml mouse 
glial cell line-derived neurotrophic factor (GDNF, Peprotech, Rocky Hill, NJ, 450-44) 
with 2 mg/ml bovine serum albumin (BSA, Sigma, 10735094001) in water. For calcium 
imaging experiments, cultures were also supplemented with 50 ng/ml mouse nerve 
growth factor ß (NGF, Peprotech, 450-34) with 2 mg/ml BSA in water. 
 
Cell immunofluorescence 
All cell and tissue immunofluorescence steps were completed at room temperature, 
apart from overnight incubations, which were conducted at 4°C. For cell 
immunohistochemistry, media was carefully aspirated 24  1 h post-plating, and cells 
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fixed with 4% (w/v) paraformaldehyde (PFA, Electron Microscopy Sciences, Hatfield, 
PA) for 20 min; 16% PFA stock was diluted in phosphate buffered saline (PBS, 137 
mM NaCl [Sigma, S3014], 10 mM Na2HPO4 [Sigma, S3264], 2.7 mM KCl [Sigma, 
P9541], 1.8 mM KH2PO4 [Sigma, P9791]) to achieve the final working solution. Cells 
were permeabilised for 30 min using 0.3% (w/v) Triton X-100 (Sigma, T8787) in PBS, 
before blocking for 30 min in permeabilisation solution containing 5% (w/v) BSA, and 
probing overnight with primary antibodies (see below) in block solution. Triton X-100 
was omitted in the non-permeabilisation protocol. The following day, coverslips were 
washed three times for 10 min in PBS, probed with secondary antibodies (see below) 
and 4',6-diamidino-2-phenylindole, dihydrochloride (DAPI, Thermo Fisher, D1306) 
for 2 h, and washed three times with PBS, before mounting on slides in fluorescence 
mounting medium (Dako, Glostrup, Denmark, S3023). Slides were kept at 4°C and 
allowed to set overnight before imaging. 
 
Tissue processing for immunofluorescence 
L1-L5 DRG were dissected and fixed in 4% PFA for 2 h, before washing in PBS, and 
equilibrating in 20% (w/v) sucrose (Sigma, S7903) in PBS overnight. Plantar punches 
were collected from the right hind paw using a 5 mm punch (Sigma, Z708771), fixed 
in 4% PFA overnight, placed in decalcifying solution (15% sucrose, 10% [w/v] 
ethylenediaminetetraacetic acid [EDTA, Sigma, ED2SS], 0.07% [w/v] glycerol 
[Sigma, G5516] in PBS) overnight, and treated with 20% sucrose in PBS overnight (6). 
Soleus muscles and spinal cords were dissected from mice transcardially perfused with 
4% PFA at a rate of ≈3 ml/min for 4-5 min. Soleus muscles were post-fixed for 2 h, 
before washing with PBS and leaving in 20% sucrose overnight (7). Spinal cords were 
post-fixed overnight, washed with PBS, and placed in 20% sucrose overnight. The 
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embryonic day 18.5 (E18.5) Kidins220-/- brain (8), used as a positive control for 
activated caspase 3 staining (Fig. S3), was dissected in PBS, fixed for 2 h in 4% PFA, 
washed in PBS, and equilibrated in 20% sucrose in PBS overnight. All sucrose-treated 
tissues were embedded in Tissue-Tek O.C.T. Compound (Sakura Finetek, Torrance, 
CA, 4583), frozen on dry ice-chilled methanol (Sigma, 32213), and kept at -80°C. 10 
μm DRG, one and three month plantar punch, and E18.5 brain sections, 12 μm soleus 
muscle sections, 20 μm P1 plantar punch sections, and 30 μm spinal cord sections were 
cut with an OTF Cryostat (Bright Instruments, Huntingdon, UK) and collected on 
polysine-coated slides (VWR, 631-0107). Transverse sections were cut from all tissues, 
except for the E18.5 Kidins220-/- brain (coronal), and the DRG, which were sectioned 
in stochastic orientations due to their spherical nature. Spinal cords were sectioned onto 
12 parallel slides, L1-L5 DRG and the E18.5 brain onto eight parallel slides, soleus 
muscles and plantar punches on to four parallel slides, and all L5 DRG sections for 
neuron cell counts were collected onto 1-2 slides/DRG. All sections were air dried for 
30-60 min before staining or freezing at -80°C, except for spinal cord sections, which 
were air dried overnight. 
 
Tissue immunofluorescence 
Sections were encircled with a hydrophobic barrier pen (Dako, S2002) on microscope 
slides, permeabilised by three 10 min washes with 0.3% Triton X-100 in PBS, and 
blocked for 1 h in 10% BSA and 0.3% Triton X-100 in PBS. To facilitate synaptic 
labelling, spinal cord sections were incubated for 30 min in 50% (v/v) ethanol in water, 
followed by 10 min in hot (>95°C) citrate-EDTA buffer (10 mM citric acid [Sigma, 
W302600], 2 mM EDTA, final pH 6.2 - adjusted with 10 M NaOH [Sigma, 72068]), 
10 min in 4 μg/ml Proteinase K (Merck Millipore, Billerica, MA, 124568) in PBS 
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containing 0.3% Triton X-100, and 10 min in 1 mg/ml pepsin (Dako, S3002) in 0.2 M 
HCl (Sigma, 258148) at 37°C. Samples were then probed overnight with primary 
antibodies (see below). The following day, sections were processed in the same way as 
primary DRG neuron coverslips (see above), bathed in fluorescence mounting medium, 
and covered with 22 × 50 mm cover glass (VWR, 631-0137). E13.5 hind feet were 
removed from embryos between the ankle and knee joints and processed, with subtle 
modifications, as previously described (9). Briefly, feet were fixed for 4 h in 4% PFA, 
followed by overnight bleaching in 15% hydrogen peroxide (Sigma, H1009) and 1.5% 
dimethyl sulphoxide (DMSO, Sigma, D1435) in methanol. The following day, feet 
were moved to 10% (v/v) DMSO in methanol overnight, before application of primary 
antibody (see below) in block solution (5% normal goat serum [Sigma, G9023] and 
20% DMSO in PBS) for five days. Feet were subsequently washed five times in PBS 
for 1 h, before applying secondary antibody in block overnight. Finally, feet were 
washed three times in PBS for 1 h before mounting on microscope slides in Dako 
medium, and covering with 22 × 50 mm cover glass. 
 
Antibodies for immunohistochemistry 
The following primary antibodies were used (Tables S1-2) for immunofluorescence 
and western blotting: sheep anti-calcitonin gene-related peptide (CGRP, Enzo Life 
Sciences, Farmingdale, NY, BML-CA1137), goat anti-choline acetyltransferase 
(ChAT, Merck Millipore, AB144P), rabbit anti-cleaved-caspase 3 (Cell Signaling 
Technology, Danvers, MA, 9661), rabbit anti-extracellular signal-regulated kinases 1 
and 2 (ERK1/2, Cell Signaling Technology, 9102), rabbit anti-p-ERK1/2 (Cell 
Signaling Technology, 9101), mouse anti-FLAG (Sigma, F1804), mouse anti-
glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Merck Millipore, MAB374), 
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rabbit anti-laminin (Sigma, L9393), rabbit anti-NeuN (Abcam, Cambridge, UK, 
ab177487), mouse anti-neurofilament (2H3, developed by Thomas M. Jessell and Jane 
Dodd, Developmental Studies Hybridoma Bank, Iowa City, IA, supernatant), mouse 
anti-NF200 (Sigma, N0142), rabbit anti-parvalbumin (Swant, Marly, Switzerland, 
PV27), rabbit anti-peripherin (Merck Millipore, AB1530), rabbit anti-PGP9.5 
(UltraClone, Isle of White, UK, 31A3), rabbit anti-PSD95 (Frontier Institute, Ishikari, 
Japan, Af628), mouse pan anti-synaptic vesicle 2 (SV2, developed by Kathleen M. 
Buckley, Developmental Studies Hybridoma Bank, Iowa City, IA, concentrate), guinea 
pig anti-synaptophysin (Frontier Institute, Af300), rabbit anti-TrkB (Merck Millipore, 
07-225), rabbit anti-TRPV1 (Alomone Labs, Jerusalem, Israel, ACC-030), chicken 
anti-βIII-tubulin (Abcam, ab41489), mouse anti-βIII-tubulin (Covance, Princeton, NJ, 
mms-435P), and mouse anti-V5 (Invitrogen, Carlsbad, CA, R960CUS). For 
immunofluorescence, tissues were also sometimes incubated with 1 mg/ml isolectin B4 
(IB4) biotin conjugate from Bandeiraea simplicifolia (Sigma, L2140) in PBS at 1/250. 
The following day, combinations of AlexaFluor secondary antibodies (Thermo Fisher, 
A-10040, A-11001, A-11008, A-11034, A-11039, A-11055, A-11074, A-21235, A-
21236, A-21245, A-21424, A-21429, A-21436) at 1/1,000, 2 mg/ml streptavidin, 
Pacific Blue conjugate (Thermo Fisher, S-11222) or streptavidin, AlexaFluor 488 
conjugate (Thermo Fisher, S-11223) at 1/250, and DAPI at 1/1,000 in PBS were used. 
 
Cell imaging and analysis 
Mounted cells were imaged using an Axioplan 2 microscope (Zeiss, Oberkochen, 
Germany) or a LSM 780 laser scanning microscope (Zeiss), and single plane images 
analysed using ImageJ software (https://imagej.nih.gov/ij/). Cell bodies and processes 
of DRG neurons were visualised using the pan-neuronal marker βIII-tubulin. To 
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calculate the percentage of cells bearing neurites an average of 788 cells/coverslip were 
scored. Neuronal processes shorter than approximately half of the diameter of the cell 
body of the largest neurons (≈15 μm), as assessed by eye, were not counted as neurites. 
Neurite lengths were measured by manually plotting points along the length of a cell’s 
longest process, and an average of 51 cells/coverslip were assessed. Cell body area was 
measured by manually drawing around the circumference of the cell body, and an 
average of 202 cells/coverslip were assessed. To assess activated caspase 3 staining, 
the average fluorescence intensity of βIII-tubulin+ cell bodies was calculated for each 
coverslip, and the mean cell body fluorescence from the secondary only control was 
subtracted. DRG neurons were plated onto multiple coverslips, which were then PFA-
fixed at different times post-plating (4, 48, and 96 h). Coverslips were simultaneously 
processed, and images acquired with the same confocal settings, so that fluorescence 
intensity could be compared across time points. An average of 57 cells/coverslip were 
assessed for cleaved-caspase 3 intensity. To categorise neurons, cells were divided into 
small (<315 μm2), medium (315-706 μm2), and large (>706 μm2) groups based on 
previously published criteria (10), and an average of 202 cells/coverslip were assessed. 
To assess the percentage of βIII-tubulin+ cells expressing NF200, an average of 241 
cells/coverslip were scored by eye. All DRG culture analyses include multiple 
coverslips (1-3)/animal and were performed blinded to genotype. 
 
Tissue imaging and analysis 
All mounted tissues, except for spinal cord sections, were imaged using a LSM 780 
laser scanning microscope (Zeiss), and images analysed using ImageJ software. Spinal 
cord sections were imaged with a LSM 710 laser scanning microscope (Zeiss). To 
measure the area of βIII-tubulin+ profiles in L1-L5 DRG sections, z-stack images were 
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taken with a 20x objective, and 3D projected (Max Intensity) images used to draw 
around the circumference of cell profiles. The areas of 300 profiles/DRG were averaged 
from three DRG to generate a single mean value for each mouse. Single plane, tile scan 
images of L1-L5 DRG sections were taken with a 10x or 20x objective to calculate the 
percentages of CGRP+, IB4+, NF200+, peripherin+, and parvalbumin+ cells, and 
measure average TRPV1 fluorescence intensity. The Cell Counter ImageJ plugin was 
used to avoid re-counting cells, and an average of 470 profiles/DRG from three DRG 
were scored and used to calculate a mean percentage value for each mouse. Anti-
TRPV1 stained sections were converted to black and white, and inverted, before 
thresholding uniformly across samples in order to identify TRPV1+ neurons. The 
Freehand Selection tool was then used to measure the average cytoplasmic fluorescence 
intensity per TRPV1+ cell. The mean value of these TRPV1 intensities was calculated 
for three separate DRG. The average of the three mean values was calculated, and the 
mean background fluorescence level from secondary only control slides subtracted to 
produce a value for each animal. An average of 15 cells/DRG section were analysed. 
Activated caspase 3 levels were assessed by measuring the average fluorescence 
intensity of each DRG section, and subtracting from this value the fluorescence of 
secondary-only control sections. All slides within a time point (i.e. P1, one, and three 
months) were processed in parallel and images acquired in the same session with 
identical settings. Three sections/DRG were used to produce a mean value for each 
DRG, which was then averaged across three DRG to get a cleaved-caspase 3 
fluorescence intensity for each mouse. To perform βIII-tubulin+ profile counts in L5 
DRG, the volume of each DRG (in mm3) was estimated by calculating the mean area 
(in mm2) of 15-17 evenly-spaced sections and then multiplying this value by the 
thickness and number of sections taken for each DRG (71-116). The number of βIII-
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tubulin+ profiles was counted in each of the sections and averaged to get an estimate of 
neuron density (neurons/mm3). DRG volume and neuron density values were then used 
to estimate the number of profiles/L5 DRG. For soleus muscle spindle analyses, a full 
series of sections across the length of each muscle was used to count the number of 
spindles. Muscle spindles were identified based on SV2/2H3 fluorescence and, because 
this antibody combination is also used to visualise NMJs (11), stereotypical 
architecture. Spindle innervation status was assessed by eye by scoring the percentage 
of spindles displaying the characteristic circular SV2/2H3 fluorescence surrounding 
central, large circular nuclei (e.g. Fig. 3A, wild-type). Spindles lacking this staining 
around at least one nuclei were designated as not fully innervated (e.g. Fig. 3A, 
GarsC201R/+). All spindles within each muscle were assessed. To analyse intraepidermal 
nerve fibre density, z-stack images of the epidermis were taken of the central region of 
the lateral edge of glabrous hind paw using a 20x objective. Images were 3D projected 
(Max Intensity), uniformly thresholded across samples (PGP9.5 staining assigned to 
black and background to white), and all particles analysed within the epidermis. The 
summed pixel area was then divided by the epidermis area to get percentage coverage 
of PGP9.5 staining/10 μm section. This value was halved for P1 samples, which were 
sectioned at twice the thickness of the one and three month plantar punches. Samples 
within time points were simultaneously processed and imaged with identical 
microscope settings. Six to eight sections were used to generate mean values for each 
animal, and secondary only control slides were used to ensure that background 
fluorescence did not impact the final result. To assess E13.5 sensory nerve targeting of 
the hind limbs, single-plane, tile scan images were taken with a 20x objective. Images 
were then used to measure the distances between the ventral and dorsal main nerve 
trunk endings to the tips of the developing digits. The average distance of 2-6 nerves 
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was calculated to produce values for each embryo. Nerve branching in the dorsal foot 
plate was also assessed by calculating the number of branches per mm of the longest 
length of each major nerve trunk and then averaging those values to produce a score for 
each embryo, similar to previously reported (12). In order to prevent subtle differences 
in developmental stage impacting the result, statistical analyses at E13.5 were 
performed not on raw data but values relative to the wild-type mean. For spinal cord 
synaptic content, three sections were assessed per animal, and for the motor neuron 
analysis, four ventral horns were imaged per animal. All images were captured with a 
voxel size of 40 × 40 nm by 100 nm depth using a x63 Plan-Apochromat objective. To 
analyses synapse numbers, a single image slice (≈75 μm width × 150 μm height) of IB4 
and PSD95 labelling was initially taken across one randomly selected superficial dorsal 
horn, including laminae I-III, from the tissue section under analysis. Using the freehand 
drawing tool and ROI (Region of Interest) Manager in ImageJ and IB4 labelling as a 
marker of lamina II, this reference image was used to delineate regions of interest 
consisting of lamina I, II outer, II inner, and III. These regions of interest were used for 
assessing synapse densities across the different laminae of the dorsal horn. Sample 
image stacks were also captured of the same region, taken to a depth of 5.5 μm, and 
processed to derive binary representations of synaptic puncta. Firstly, stacks were 
deconvolved in ImageJ using the WPL deconvolution algorithm in the Parallel Iterative 
Deconvolution software package (13), based on the Iterative Deconvolve 3D plugin 
(14). 3D PSFs were generated in PSF Lab (15). Deconvolved image stacks were then 
filtered with the “despeckle” 3 × 3 median filter and thresholded using the OTSU 
method in ImageJ. To assess puncta within each region of interest, the image stack was 
divided into eight equally spaced image slices (0.1 μm z slices separated by 0.5 μm). 
Each region on the isolated slices was assessed separately for PSD95+ and 
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synaptophysin+ puncta profiles using the Analyze Particles plugin in ImageJ. Puncta 
profile counts for each lamina were averaged across three tissue sections per animal, 
and plotted as puncta profile numbers per 100 μm2 of lamina. To assess motor neuron 
subtype proportions, z-stack images of the entire section depth were maximally 
projected, the border of the lateral-medial nucleus of lamina IX delineated, and the 
number of ChAT+, NeuN+, and ChAT+/NeuN+ neurons quantified. From this data, the 
number of alpha (ChAT+/NeuN+) and gamma (ChAT+/NeuN-) neurons were calculated 
as a proportion of total neurons. All phenotypic analyses in this study were performed 
blinded to genotype. 
 
Sensory behaviour testing 
For all sensory behaviour tests, mice were pre-acclimatised to the testing equipment 
and an average of 2-3 baseline readings were used to obtain a final measurement. To 
assess mechanosensation, von Frey monofilaments were applied to the plantar surface 
of the hind paw and removal of the paw recorded as a positive response. A response 
threshold value was calculated using the up and down method (16). Proprioception was 
assessed using the beam walk test as previously described (17). Briefly, mice were 
filmed as they moved across a thin wooden beam of roughly one meter in length. The 
percentage of correct steps was calculated by recording the number of missed hind paw 
placements and hops, and comparing to the total number of steps taken for each run. 
Noxious mechanical thresholds were calculated with the use of an Analgesy-Meter 
(Ugo Basile, 37215) (18). Mice were lightly restrained and increasing mechanical 
pressure was applied either to the dorsum of the paw or to the base of the tail. The force 
at which an obvious withdrawal response was observed was taken as the withdrawal 
threshold. To assess heat sensitivity, the Hargreaves method was used (19). A radiant 
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heat source was applied to the plantar surface of the hind paw and the latency to 
withdrawal was measured as the noxious heat threshold. All tests were carried out with 
the experimenter blind to genotype. 
 
Motor behaviour testing 
Motor behaviour was assessed using a Grip Strength Meter (Bioseb, Vitrolles, France, 
GS3) and an accelerating Rota-Rod (Ugo Basile, Monvalle, Italy, 47600) as previously 
described (2, 20). Rota-Rod testing was sometimes performed before grip strength 
testing on the same day with at least a 30 min interval between tests. Mice were tested 
on two or three days within a week. Three trials were performed per animal per test 
day, with at least 5 min rest between trials. The maximum recorded value from the three 
trials in a day was used to calculate a mean value across days for each mouse.  
 
Measurement and analysis of cytosolic calcium 
Cytosolic calcium in primary DRG neurons was assessed as previously described (21). 
Briefly, cells were washed twice with recording medium (156 mM NaCl, 10 mM D-
glucose [Sigma, G8270], 10 mM HEPES [Sigma, H3375], 3 mM KCl [Sigma, P9333], 
2 mM CaCl2 [Sigma, C8106], 2 mM MgSO4 [Sigma, M7506], and 1.25 mM KH2PO4, 
final pH 7.34-7.36 - adjusted with 10 M NaOH), and loaded with 5 μM fura-2 AM 
(Thermo Fisher, F1221) and 0.002% (v/v) pluronic acid F-127 (Thermo Fisher, 
P3000MP) in recording medium for 30 min at room temperature. Fura-2 was 
subsequently removed and cells washed twice in recording medium before cytosolic 
calcium was detected in single cells every 2 s using an IX70 inverted microscope 
(Olympus, Tokyo, Japan), a cooled Retiga Fast 1394 CCD camera (QImaging, Surrey, 
Canada), and Andor iQ 1.9 software (Belfast, UK). Following at least 90 s continuous 
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recording of the baseline fura-2 ratio, the medium was carefully replaced with recording 
medium containing either 50 mM KCl or 1 μM capsaicin (Sigma, M2028). To calculate 
the fura-2 ratio change from baseline to maximal response for individual cells, the mean 
of 20 sequential recordings post-stimulation was divided by the mean of 20 sequential 
baseline recordings prior to stimulation. The mean average was then calculated for all 
cells simultaneously imaged in a well. An average of 10 cells per well was assessed. 
Capsaicin responsive and non-responsive cells were categorised based on whether the 
percentage fura-2 ratio change was  150% or < 150%, respectively. Fura-2 
experiments include multiple wells (2-3)/treatment/animal. 
 
Cell culture and transfection 
NSC-34 and N2a neuroblastoma cells stably transfected with human TrkB N-terminally 
tagged with FLAG (22) were grown in Dulbecco’s Modified Eagle Medium (DMEM, 
Thermo Fisher, 41966) supplemented with 10% FBS (Omega Scientific, Singapore or 
Thermo Fisher), and 1% penicillin-streptomycin. N2a media was also supplemented 
with 1% (v/v) GlutaMAX (Thermo Fisher, 35050061). Cells were maintained at 37°C 
in a 5% CO2 humidified atmosphere and split every 2-3 days using 0.25% (v/v) trypsin-
EDTA (Thermo Fisher, 25200). For immunofluorescence, N2a cells were plated onto 
PDL-treated coverslips at 2.5 × 105 cells/well and left overnight before processing (as 
outlined above). NSC-34 cells were grown to ≈70% confluency and transfected with 
pcDNA6 plasmids expressing human wild-type, P234KY, or C157R GARS with a C-
terminal V5 tag using Lipofectamine 2000 (Invitrogen, 116680) according to 
manufacturer’s instructions. 
 
Protein extraction 
 15 
L1-L5 DRG were dissected from one month old, PBS-perfused (see above) mice, and 
collected into microcentrifuge tubes containing PBS, which were spun down to pellet 
the ganglia and remove the PBS, before snap freezing in liquid nitrogen. Samples were 
subsequently thawed on ice, and ground up with a plastic mortar and pestle (VWR, 
431-0094) in RIPA lysis buffer (150 mM NaCl, 50 mM Tris-HCl [Sigma, T3253, pH 
7.5], 1% [w/v] sodium deoxycholate [Sigma, D6750], 1% Triton X-100, 0.1% [w/v] 
sodium dodecyl sulphate [Sigma, L3771]), and left for 30 min on ice, before clearing 
for 20 min at 10,000 × g. For pull-down experiments, 36 h post-transfection NSC-34 
cells were twice washed in PBS, collected in microcentrifuge tubes, pelleted, and re-
suspended in Pierce IP Lysis Buffer (Thermo Fisher, 87787) for 30 min, and the extract 
cleared for 7 min at 12,000 × g. Protein was extracted from N2a cells in a similar 
manner using NP-40 lysis buffer (150 mM NaCl, 10 mM Tris-HCl [pH 8.0], 1% 
IGEPAL CA-630 [Sigma, I3021], 1 mM EDTA). Halt protease and phosphatase 
inhibitor cocktail (Thermo Scientific, 78445) was freshly added to RIPA and NP-40 
lysis buffers. 
 
In vitro pull-down assay 
Recombinant human TrkA (R&D Systems, Minneapolis, MN #175-TK), TrkB (R&D 
Systems, #688-TK), and TrkC (R&D Systems, #373-TC/CF) Fc chimeras were bound 
to Protein G beads (Invitrogen). NSC-34 cell extracts containing the V5-tagged WT, 
P234KY, or C157R GlyRS were individually added to the receptor-immobilised beads 
and incubated for 1 h at 4°C. The beads were then washed three times with buffer (100 
mM NaCl, 50 mM Tris-HCl [pH 7.5], 5% glycerol, 0.1% Triton X-100), and the 
immunoprecipitates probed by western blot analysis against the V5 tag. 
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Western blotting 
Immunoprecipitates and protein lysates were fractionated by 4-12% or 4-15% (v/v) Bis-
Tris-Plus SDS-PAGE gels (Invitrogen or Bio-Rad, Hercules, CA) and transferred to 
PVDF membranes using the iBlot Dry Blotting System (Invitrogen) or Trans-Blot 
Turbo Transfer System (Bio-Rad). Membranes were blocked for 1 h with Tris-buffered 
saline containing 0.1% (v/v) Tween 20 (Sigma, P2287) and 5% (w/v) non-fat dry milk 
or 5% BSA (for anti-phospho antibodies), before exposure to primary antibodies in 
blocking solution overnight (see above). The following day, membranes were washed 
and probed with HRP-conjugated anti-mouse or anti-rabbit secondary antibodies (Cell 
Signaling Technology or Dako), followed by detection using ECL western blotting 
substrate (Thermo Fisher Scientific or Merck Millipore) and exposure using the 
ChemiDoc Touch Imaging System (Bio-Rad). Densitometry analysis was performed as 
described previously (4). ERK1/2 phosphorylation levels were compared by running 
the same lysates in two parallel gels, and probing one for total ERK1/2 and the other 
for p-ERK1/2. 
 
Trk activation assays 
N2a cells were plated in 2 ml media in 6-well plates at 1.5x106 cells/well, and serum-
starved 3 h later for 3 h by replacing the media with DMEM lacking FBS. The cell 
media was then aspirated and replaced with fresh media containing an equivalent 
volume of PBS (<1% v/v), 150 nM wild-type, L129P, or G240R GlyRS; the applied 
extracellular concentration of GlyRS was similar to previously published studies (23, 
24). One well per plate was left untreated to assess perturbations in ERK 
phosphorylation caused by temporary removal from the incubator. After 5, 15, or 30 
min incubations, cells were placed on ice, lysed, and analysed by western blot as 
 17 
outlined above and described recently elsewhere (22). Recombinant GlyRS proteins 
were produced as previously described (24). 
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Supplementary Figure 1. Different classes of mutant sensory neuron, based on cell 
soma size, are equally unaffected. (A) Small (<315 μm2), medium (315-706 μm2), 
and large (>706 μm2) area sensory neurons show no difference in the longest neurite 
length between wild-type and GarsC201R/+ cultures. Neurons were stained with anti-βIII-
tubulin. P = 0.05, Kruskal-Wallis test, P > 0.05, Dunn’s multiple comparison tests 
between wild-type and mutant samples of all cell sizes (excluding “All” category, 
which was tested in Fig. 1A, top right). (B) There is also no evidence for greater cell 
death, as assessed by measuring activated caspase 3 fluorescence intensity per neuron. 
4 h time point, P = 0.047, Kruskal-Wallis test, P > 0.05, Dunn’s multiple comparison 
tests between wild-type and mutant samples of all cell sizes; 48 h time point, two-way 
ANOVA (P = 0.018, cell body size; P = 0.729, genotype; P = 0.739, interaction); 96 h 
 22 
time point, two-way ANOVA (P = 0.362, cell body size; P = 0.071, genotype; P = 
0.099, interaction). a.u., arbitrary units. n = 4. 
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Supplementary Figure 2. Immunohistochemical analysis of functional sensory 
neuron subtype markers. (A) Different functional classes of sensory neurons can be 
identified based on the expression of marker proteins. NF200 and peripherin are mostly 
exclusively expressed in medium-large (A-fibres) and small (Aδ and C-fibres) sensory 
nerves, respectively. NF200+ cells lacking parvalbumin expression are considered to be 
mechanoreceptive neurons, while those that are parvalbumin+ are proprioceptive (A, 
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left-hand side). Peripherin+ cells that co-stain with isolectin B4 (IB4), but not calcitonin 
gene-related peptide (CGRP), are non-peptidergic, mainly mechanical nociceptors, and 
those peripherin+ cells that are labelled with CGRP, but not IB4, are peptidergic, 
principally thermal, nociceptors (A, right-hand side). (B) Representative example of 
co-staining with DAPI (white), peripherin (green), and NF200 (red). The asterisk 
highlights a NF200+/peripherin- medium-large neuron, and the arrowhead marks a 
NF200-/peripherin+ small neuron. The arrow identifies an infrequently seen (≈2-3%) 
cell type that expresses both NF200 and peripherin. A second such cell (yellow) can be 
seen towards the bottom of the merged image. (C) Representative example of co-
staining with βIII-tubulin (white), parvalbumin (green), and NF200 (red). The asterisk 
identifies a NF200+/parvalbumin- cell likely to be a mechanoreceptive sensory neuron, 
the arrow marks a NF200+/parvalbumin+ proprioceptive nerve, and the arrowhead 
highlights a rare NF200-/parvalbumin+ cell. (D) Representative example of co-staining 
with peripherin (white), IB4 (green), and CGRP (red). The arrowhead identifies a 
peripherin+/IB4+/CGRP- neuron, which is likely a mechanosensitive nociceptor, the 
asterisk marks a peripherin+/IB4-/CGRP+ nociceptor probably sensitive to noxious 
thermal stimuli, and the arrow highlights an uncommon (≈1%) example of a peripherin-
/IB4-/CGRP+ cell. All images are collapsed z-stacks taken of one month wild-type 
DRG. Scale bars = 50 μm. 
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Supplementary Figure 3. GarsC201R/+ DRG show no signs of sensory neuron loss at 
one month. (A) Representative single confocal plane images of one month old wild-
type (left) and GarsC201R/+ DRG sections stained for the apoptotic marker cleaved-
caspase 3. DRG sections are outlined by dashed lines. (B) There is no difference in 
cleaved-caspase 3 fluorescence intensity between wild-type and mutant DRG. P = 
0.812, unpaired t-test. a.u., arbitrary units. (C) Representative cleaved-caspase 3 
staining of a section taken from an E18.5 Kidins220-/- brain, which was used as a 
positive control. Inset images depict the region of the coronal section (bottom left), and 
the area of the section that was imaged (top right). (D) Representative images of serial 
sections taken from a single wild-type L5 DRG and stained with βIII-tubulin (red). The 
number in the top left of each panel depicts the section number. Serial sections were 
taken throughout the entire length of the DRG in order to estimate the number of 
sensory neurons per L5 ganglion. (E) βIII-tubulin+ cell profile estimates indicate that 
GarsC201R/+ L5 DRG show no signs of sensory neuron loss. P = 0.849, unpaired t-test. 
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n = 4. All images are single confocal planes. Scale bars = 200 μm (A, D) and 50 μm 
(C). 
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Supplementary Figure 4. The proportions of alpha and gamma spinal cord motor 
neurons are unaffected in GarsC201R/+ mice. (A) The cell bodies of alpha and gamma 
motor neurons located in the ventral horn of the spinal cord can be differentiated by 
marker protein expression. Based on their size and location in lamina IX, cells 
 28 
expressing choline acetyltransferase (ChAT) and NeuN are alpha motor neurons, while 
ChAT+/NeuN- cells are gamma motor neurons. (B) Representative collapsed z-stack 
image of one month old wild-type spinal cord section stained for ChAT (green) and 
NeuN (red). Example alpha (arrowhead) and gamma (arrow) motor neurons are 
identified. Scale bar = 100 μm. (C) At one month, there is no difference between wild-
type and GarsC201R/+ mice in the proportion of alpha or gamma motor neurons found in 
lamina IX of the spinal cord. Two-way ANOVA (P < 0.001, motor neuron subtype; P 
= 0.763, genotype; P = 0.950, interaction). n = 3. 
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Supplementary Figure 5. Gars mouse DRG defects correlate with mutant severity. 
(A) Representative single confocal plane images of one month old DRG taken from 
wild-type (left) and the more severe CMT2D mutant mouse model, GarsNmf249/+, stained 
for peripherin (green) and NF200 (red). Scale bars = 100 μm. (B-C) GarsNmf249/+ mice 
display a significant reduction in the percentage of NF200+ cells (B, P < 0.001, one-
way ANOVA), and a concomitant increase in the percentage of peripherin+ cells (C, P 
< 0.001, one-way ANOVA) compared to both wild-type and GarsC201R/+ mice. NS, not 
significant, * P < 0.05, *** P < 0.001, Sidak’s multiple comparisons test. GarsC201R/+ 
data are taken from Fig. 2. (D) There is no evidence for increased levels of cell death 
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in the GarsNmf249/+ DRG, as assessed by activated caspase 3 staining. a.u., arbitrary 
units. P = 0.882, unpaired t-test. n = 4-5. 
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Supplementary Figure 6. Synaptic densities in dorsal horn laminae I-III remain 
unchanged in one month old Gars mice. (A) Representative collapsed z-stack image 
of a spinal cord section from a one month old wild-type mouse stained for the post-
synaptic marker PSD95 (green, bottom), the pre-synaptic protein synaptophysin (red, 
bottom right), and IB4 (blue, bottom left) to identify lamina II and delineate regions of 
interest. The schematic (top) depicts the region of the dorsal horn that was imaged. (B) 
Representative images of the deconvolution and thresholding processes used to analyse 
synapse numbers in distinct laminae (see methods). (C) There is no difference in 
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synapse density in dorsal horn laminae I-III between wild-type and GarsC201R/+ mice 
when using either PSD95 (two-way ANOVA, P < 0.001, lamina; P = 0.170, genotype; 
P = 0.472, interaction) or synaptophysin (two-way ANOVA, P = 0.002, lamina; P = 
0.847, genotype; P = 0.908, interaction) to assess synapse numbers. Intra-laminae 
comparisons between genotypes also show no difference (P > 0.05, Sidak’s multiple 
comparisons test). IIo and IIi, outer and inner regions of lamina II, respectively. n = 4. 
Scale bars = 20 μm (A) and 2 μm (B). 
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Supplementary Figure 7. GarsC201R/+ mice display motor defects that remain 
relatively stable from one to three months. (A-B) Both female and male GarsC201R/+ 
mice show a significant reduction in grip strength compared to wild-type mice of the 
same sex at one (A, two-way ANOVA, P = 0.854, sex; *** P < 0.001, genotype; P = 
0.616, interaction) and three (B, two-way ANOVA, P < 0.001, sex; *** P < 0.001, 
genotype; P = 0.037, interaction) months. (C-D) Similarly, GarsC201R/+ mice show a 
significant reduction in the time taken to fall off an accelerating Rota-Rod at one (C, 
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two-way ANOVA, P = 0.326, sex; ** P = 0.007, genotype; P = 0.188, interaction) and 
three months (D, two-way ANOVA, P < 0.001, sex; * P = 0.010, genotype; P = 0.972, 
interaction). In both behavioural tests, the mutant defects remained relatively stable 
from one to three months (female grip strength, P = 0.523; male grip strength, P = 
0.155; female Rota-Rod, P = 0.556; male Rota-Rod, P = 0.590, unpaired t-test). The 
statistical tests of significance represented on the figures were performed on raw data 
(Supplementary Tables 8 and 9), while the percentages relative to wild-type, which are 
plotted, were used to compare mutant progression over time. n = 6. 
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Supplementary Figure 8. Longitudinal analysis of cell death in lumbar DRG and 
intraepidermal nerve fibre density in glabrous hind paw. (A) There is no difference 
in the cleaved-caspase 3 fluorescence intensity per neuron between wild-type and 
GarsC201R/+ DRG at any time point tested, suggesting that cell death is not accounting 
for the observed DRG cellular phenotype. Two-way ANOVA (P < 0.001, age; P = 
0.444, genotype; P = 0.413, interaction). 1 mo, 1 month; 3 mo, 3 months. (B) PGP9.5 
staining in the hind paw epidermis of wild-type mice decreases progressively from P1 
to three months. GarsC201R/+ mice show no difference at P1, significantly more 
innervation at one month, but then no difference again at three months. Two-way 
ANOVA (P = 0.002, age; P = 0.013, genotype; P = 0.132, interaction). * P < 0.05, ** 
P < 0.01, Sidak’s multiple comparisons test. n = 3-5 (A) and 4-6 (B). Data from the one 
month time point in panels A and B are taken from Fig. S3B and Fig. 3E, respectively. 
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Supplementary Figure 9. CMT2D sensory nervous system pathology. Gars 
mutations distort the proportions of sensory neuron subpopulations in the DRG, such 
that mutant mice have fewer medium-large (red, NF200+) and more small (green, 
peripherin+) area neurons from birth to at least three months (1). This does not affect 
synapse numbers within distinct spinal cord dorsal laminae (2), but may account for the 
previously reported (2) reduced axon calibre of sensory nerves (3) and the diminished 
number and innervation of muscle spindles in the soleus (4), both of which likely 
contribute to mutant mechanosensation and proprioception deficiencies (5). 
Furthermore, mutant Gars nociceptors show delayed pruning in peripheral tissue (6), 
hyperexcitability likely due to increased TRPV1 expression (7), and increased sensory 
nerve action potential (SNAP) amplitudes, as previously reported (2) (not shown). 
These phenotypes may explain the pain hypersensitivity observed in Gars mice (8). 
Together, our work indicates that CMT2D may arise from the intricate interaction 
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between subverted neurodevelopment and neurodegeneration. Scale bars = 100 μm (1), 
50 μm (2 and 6), and 20 μm (4). The unaltered pictures of transverse sensory nerves (3) 
were taken from Achilli et al. 2009 (2) with permission under the Creative Commons 
Attribution (CC-BY 3.0) license (http://creativecommons.org/licenses/by/3.0/). 
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Antigen 
Source 
(Product #) 
Host species 
 
(clonality) 
                       Concentration used    
DRG 
culture 
DRG Skin 
axon 
Muscle 
spindle 
Spinal 
cord 
E18.5 
brain 
E13.5 
feet 
N2a 
cells 
WB 
CGRP ELS 
(BML-CA1137) 
Sheep 
(P) 
- 1/200 - - - - - - - 
ChAT Merck 
AB144P 
Goat 
(P) 
- - - - 1/100 - - - - 
C-C3 CST 
(9661) 
Rabbit 
(P) 
1/500 1/500 - - - 1/500 - - - 
ERK1/2 CST 
(9102) 
Rabbit 
(P) 
- - - - - - - - 1/1,000 
p-ERK1/2 CST 
(9101) 
Rabbit 
(P) 
- - - - - - - - 1/500 
FLAG Sigma 
(F1804) 
Mouse 
(M) 
- - - - - - - 1/500 - 
GAPDH Merck 
(MAB374) 
Mouse 
(M) 
- - - - - - - - 1/3,000 
Laminin Sigma 
(L9393) 
Rabbit 
(P) 
- - - 1/1,000 - - - - - 
NeuN Abcam 
(ab177487) 
Rabbit 
(M) 
- - - - 1/500 - - - - 
NF200 Sigma 
(N0142) 
Mouse 
(M) 
1/500 1/500 Failed 
1/500 
- - - - - 1/1,000 
Parvalbumin Swant 
(PV 27) 
Rabbit 
(unknown) 
- 1/1000 - Failed 
1/500 
- - - - - 
Peripherin Merck 
(AB1530) 
Rabbit 
(P) 
Failed 
1/500 
1/500 Failed 
1/500 
- - - - - 1/1,000 
PGP9.5 UltraClone 
(RA 95101) 
Rabbit 
(P) 
- - 1/1,000 - - - - - - 
PSD95 FI 
(Af628) 
Rabbit 
(P) 
- - - - 1/200 - - - - 
SV2 DSHB 
(concentrate) 
Mouse 
(M) 
- - - 1/250 - - - - - 
Syp FI 
(Af300) 
Guinea Pig 
(P) 
- - - - 1/200 - - - - 
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Supplementary Table 1. Primary antibodies successfully used for immunofluorescence and 
western blotting. 2H3, neurofilament; C-C3, cleaved-caspase 3; CST, Cell Signaling Technology; 
DSHB, Developmental Studies Hybridoma Bank; ELS, Enzo Life Sciences; FI, Frontier Institute; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; M, monoclonal; P, polyclonal; Syp, 
synaptophysin; SV2, synaptic vesicle 2; WB, western blot. For failed staining, the highest concentration 
is reported. 
 
 
 
 
 
 
 
 
 
 
TrkB Merck 
(07-225) 
Rabbit 
(P) 
- - - - - - - 1/500 1/1,000 
TRPV1 Alomone 
(ACC-030) 
Rabbit 
(P) 
- 1/500 - - - - - - - 
βIII-tubulin Abcam 
(ab41489) 
Chicken 
(P) 
1/500 1/500 - - - - - - - 
βIII-tubulin Covance 
(mms-435p) 
Mouse 
(M) 
- 1/500 - - - - - - - 
V5 Invitrogen 
(R960CUS) 
Mouse 
(M) 
- - - - - - - - 1/3,000 
2H3 DSHB 
(supernatant) 
Mouse 
(M) 
- - - 1/250 - - 1/50 - - 
Antigen Source Host species Concentration used 
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Supplementary Table 2. Additional primary antibodies tested in the study. BD, BD Biosciences; M, 
monoclonal; P, polyclonal. For failed staining, the highest concentration tested is reported. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Product #) (clonality) DRG Muscle 
spindle 
N2a 
cells 
Parvalbumin Swant 
(PV 235) 
Mouse (M) Failed 
1/500 
Failed 
1/500 
- 
Parvalbumin Swant 
(PVG-213) 
Goat 
(unknown) 
1/500 Failed 
1/500 
- 
Peripherin Merck 
(MAB1527) 
Mouse (M) 1/200 - - 
Peripherin Santa Cruz 
(sc-28539) 
Rabbit (P) Failed 
1/50 
- - 
Runx3 Abnova 
(864-A01) 
Mouse (P) Failed 
1/100 
- - 
TrkB BD 
(610101) 
Mouse (M) - - 1/500 
Vglut1 Merck 
(AB5905) 
Goat (P) - Failed 
1/1,000 
- 
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Supplementary Table 3. Raw data generated by the von Frey test of mechanosensation at one and 
three months. ** P < 0.01, compared to wild-type using Sidak’s multiple comparisons test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 von Frey withdrawal threshold (g) 
Age (months) Wild-type GarsC201R/+ 
1 0.38  0.028 0.48  0.035 
3 0.49  0.035 0.66  0.041** 
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Supplementary Table 4. Raw data generated by the beam-walking test of proprioception at one 
and three months. *** P < 0.001, compared to wild-type using Dunn’s multiple comparison test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 % correct steps in beam-walking test 
Age (months) Wild-type GarsC201R/+ 
1 94.1  1.0 68.7  5.5*** 
3 88.7  2.0 46.8  5.9*** 
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Supplementary Table 5. Raw data generated by the Randall-Selitto test of hind paw mechanical 
nociception at one and three months. *** P < 0.001, compared to wild-type using Sidak’s multiple 
comparisons test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Randall-Selitto paw threshold (g) 
Age (months) Wild-type GarsC201R/+ 
1 123.3  9.6 76.5  5.9*** 
3 135.2  9.9 74.3  3.6*** 
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Supplementary Table 6. Raw data generated by the Randall-Selitto test of tail mechanical 
nociception at one and three months. ** P < 0.01, *** P < 0.001, compared to wild-type using Sidak’s 
multiple comparisons test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Randall-Selitto tail threshold (g) 
Age (months) Wild-type GarsC201R/+ 
1 104.1  15.3 59.6  4.6** 
3 153.0  9.6 81.9  5.2*** 
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Supplementary Table 7. Raw data generated by the Hargreaves test of thermal nociception at one 
and three months. * P < 0.05, *** P < 0.001, compared to wild-type using Sidak’s multiple comparisons 
test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Hargreaves latency to withdrawal (s) 
Age (months) Wild-type GarsC201R/+ 
1 7.06  0.53 5.44  0.46* 
3 9.03  0.53 5.84  0.41*** 
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Supplementary Table 8. Raw data generated by the grip strength test at one and three months. 
*** P < 0.001, compared to wild-type using Sidak’s multiple comparisons test. ### P < 0.001, two-way 
ANOVA comparison of genotypes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Grip strength (g) 
Female Male 
Age (months) Wild-type GarsC201R/+ Wild-type GarsC201R/+ 
1### 156.3  2.8 89.7  3.6*** 154.1  12.3 94.4  3.7*** 
3### 234.3  9.9 138.8  3.5*** 289.8  6.6 159.7  9.3*** 
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Supplementary Table 9. Raw data generated by the accelerating Rota-Rod test at one and three 
months. * P < 0.05, compared to wild-type using Sidak’s multiple comparisons test. # P < 0.05, ## P < 
0.01, two-way ANOVA comparison of genotypes. 
 Latency to fall (s) on accelerating Rota-Rod 
Female Male 
Age (months) Wild-type GarsC201R/+ Wild-type GarsC201R/+ 
1## 130.8  10.8 112.0  4.7 134.9  15.5 84.5  12.7* 
3# 128.3  8.9 101.6  12.7 86.5  6.7 60.5  8.0 
